Advertisement

Topics

Bristol-Myers boosts cancer pipeline with IFM Therapeutics acquisition

05:15 EDT 7 Aug 2017 | SmartBrief

Bristol-Myers Squibb said it will acquire IFM Therapeutics in an effort to strengthen its cancer portfolio.  -More

Original Article: Bristol-Myers boosts cancer pipeline with IFM Therapeutics acquisition

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers boosts cancer pipeline with IFM Therapeutics acquisition"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...